Format

Send to

Choose Destination
Pol J Microbiol. 2019 Dec;68(4):417-427. doi: 10.33073/pjm-2019-055. Epub 2019 Dec 5.

Colistin Resistance in Enterobacterales Strains - A Current View.

Author information

1
Department of Antibiotics and Microbiology, National Medicines Institute , Warsaw , Poland.
2
Department of Antibiotics and Microbiology, National Medicines Institute , Warsaw , Poland ; Department of Pharmaceutical and Microbiology, Medical University of Warsaw , Warsaw , Poland.

Abstract

Colistin is a member of cationic polypeptide antibiotics known as polymyxins. It is widely used in animal husbandry, plant cultivation, animal and human medicine and is increasingly used as one of the last available treatment options for patients with severe infections with carbapenem-resistant Gram-negative bacilli. Due to the increased use of colistin in treating infections caused by multidrug-resistant (MDR) bacteria, the resistance to this antibiotic ought to be monitored. Bacterial resistance to colistin may be encoded on transposable genetic elements (e.g. plasmids with the mcr genes). Thus far, nine variants of the mcr gene, mcr-1 - mcr-9, have been identified. Chromosomal resistance to colistin is associated with the modification of lipopolysaccharide (LPS). Various methods, from classical microbiology to molecular biology methods, are used to detect the colistin-resistant bacterial strains and to identify resistance mechanisms. The broth dilution method is recommended for susceptibility testing of bacteria to colistin.

PMID:
31880886
DOI:
10.33073/pjm-2019-055
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center